Case Study 23-2: COVID-19 Wastewater Surveillance — When Environmental Monitoring Becomes Population Health Surveillance

Case Study 23-2: COVID-19 Wastewater Surveillance — When Environmental Monitoring Becomes Population Health Surveillance

Background

This case study bridges Chapter 23 (environmental monitoring) and Chapter 24 (epidemiological surveillance). It examines the COVID-19 wastewater surveillance program — a technology that began as environmental monitoring and was repurposed, rapidly and at scale, as population health surveillance during the pandemic. The case illustrates the permeability of the boundary between environmental and human surveillance, and the way crisis conditions accelerate the crossing of that boundary.

In March 2020, as the COVID-19 pandemic began spreading globally, public health officials faced a fundamental measurement problem: they did not know how many people were infected. Testing was limited, many infected people were asymptomatic, and clinical data reflected only a fraction of actual cases. Traditional disease surveillance systems (discussed in detail in Chapter 24) were overwhelmed and lagged weeks behind actual transmission.

A team of researchers at Yale University published a paper in Nature Medicine in August 2020 demonstrating something remarkable: they could detect SARS-CoV-2 (the virus causing COVID-19) in wastewater — specifically, in samples of raw sewage collected before treatment at municipal wastewater plants. When community members are infected with SARS-CoV-2, they shed viral RNA in their feces, which flows into the wastewater system, where it can be detected days before clinical cases are diagnosed.

The Technology

The technique — wastewater epidemiology — was not new. Researchers had been using wastewater analysis to monitor polio, norovirus, illicit drug use, and other population-level phenomena for decades. But the COVID-19 application represented an unprecedented scale and speed of deployment.

How wastewater COVID-19 surveillance works:

Infected individuals shed SARS-CoV-2 RNA in feces
        ↓
Viral RNA flows through municipal sewer system
        ↓
Wastewater treatment plant collects samples
  (raw sewage before treatment — typically 24-hour composite samples)
        ↓
Samples preserved and transported to analytical laboratory
        ↓
Laboratory extracts RNA from samples
  (centrifugation, filtration, RNA extraction)
        ↓
Quantitative PCR (qPCR) measures concentration of SARS-CoV-2 RNA
  (result: copies of viral RNA per liter of wastewater)
        ↓
Correction for population served and wastewater flow
        ↓
Normalized result: viral concentration relative to baseline
        ↓
Data entered into national surveillance database
  (NWSS — National Wastewater Surveillance System, CDC)
        ↓
Analysis: trends over time, comparison across communities
        ↓
Public health decision-making: resource allocation, alert levels

By late 2020, hundreds of universities and municipalities were sampling wastewater for SARS-CoV-2. By 2022, the CDC had launched the National Wastewater Surveillance System (NWSS), coordinating data from more than 1,000 sampling sites covering an estimated 40% of the U.S. population.

Why Wastewater Surveillance Was Transformative

Wastewater surveillance offered several advantages over clinical surveillance:

Lead time: Viral RNA appears in wastewater 4–10 days before clinical cases surge. This gave public health officials advance warning of community transmission — a critical advantage for resource pre-positioning and alert messaging.

Coverage independence: Wastewater surveillance detects infections regardless of whether individuals seek testing. Asymptomatic infections, mild cases, and infections in individuals without health care access are all detected because all infected individuals shed viral RNA in their feces.

Cost efficiency: Sampling one wastewater treatment plant provides aggregate data on all the households it serves — potentially 100,000 or more people — far more efficiently than individual testing of that population.

Privacy (at the aggregate level): Wastewater data is inherently aggregate — it tells you that viral RNA is present in the wastewater from a service area, not that any specific individual is infected. Individual privacy is, in principle, protected because no one's specific sample can be distinguished.

The Privacy Complications

The "inherently aggregate" privacy protection is more fragile than it appears.

Dormitory and building-level sampling

Several universities implemented wastewater surveillance at the building rather than community level — sampling sewage from individual dormitory buildings. At this scale, a dormitory of 50–100 students could be identified as having COVID-19 cases. Students in the dormitory could be alerted and required to test. In some cases, universities triangulated further by sampling from individual floors.

At the building/floor level, wastewater surveillance approaches the level of identifying potential individuals. In a dormitory floor with 15 residents, a positive wastewater result combined with symptomatic reporting could narrow the field of suspected cases substantially. Several universities used positive wastewater results to mandate all residents of a building to test — a reasonable public health measure that also represented a surveillance-triggered intervention in individuals' lives.

What Wastewater Reveals Beyond COVID

Wastewater contains information about many aspects of community health and behavior:

Illicit drug use: Metabolites of illegal drugs persist through the wastewater system. Several municipalities and research groups had been monitoring wastewater for opioids, methamphetamine, and other substances before COVID, using the data to estimate community drug use prevalence
Legal pharmaceutical use: Medications including antidepressants, blood pressure drugs, and contraceptives can be detected in wastewater, providing population-level data on prescription drug use patterns
Dietary markers: Certain metabolites correlate with dietary patterns — potentially providing data on community nutrition
Hormones: Estrogen and testosterone metabolites are detectable, potentially revealing information about hormone use (including gender-affirming hormone therapy)

The COVID-19 wastewater surveillance infrastructure, once built, is available for these other applications. The sensors, laboratory pipelines, data systems, and public health reporting frameworks are in place. Using them for additional monitoring requires only an expansion of what is measured, not a new infrastructure investment.

The Function Creep Risk

In 2021, the Biden administration announced that NWSS would be used to monitor not only SARS-CoV-2 but also influenza, RSV (respiratory syncytial virus), and mpox. This expansion was justified by genuine public health value and represents a reasonable extension of established surveillance infrastructure. It is also a textbook example of function creep: infrastructure built for a specific emergency purpose expanding to cover additional applications as the emergency justification establishes the infrastructure as normal.

The Environmental-Health-Surveillance Continuum

This case study illustrates the chapter's central theme with unusual clarity: environmental monitoring (water quality testing, a well-established practice for detecting contamination) was extended to epidemiological surveillance (tracking infectious disease prevalence) which was further extended to behavioral surveillance (drug use, medication, dietary patterns).

Each step in this chain is individually defensible. Water quality monitoring protects public health. COVID-19 wastewater surveillance saved lives during a global pandemic. Drug use monitoring through wastewater has genuine public health applications. But the aggregate trajectory — from environmental testing to monitoring of individuals' pharmaceutical, dietary, and hormonal status — is not a journey any community has explicitly consented to take.

The justification for each step was the step before it: the infrastructure was already there; the laboratory capability was already developed; the data systems were already in place. This is how environmental surveillance becomes social surveillance: incrementally, defensively, with each step justified by reference to the last.

Discussion Questions

The chapter defines function creep as the expansion of surveillance technology beyond its original purpose. Is the COVID-19 wastewater surveillance expansion (to flu, RSV, mpox) a reasonable and legitimate extension, or is it function creep? What criteria would you use to distinguish between "legitimate expansion" and "function creep"?
University building-level wastewater surveillance was used to trigger mandatory COVID-19 testing for entire dormitory populations. Students had not specifically consented to wastewater monitoring when they enrolled. Was this a legitimate public health measure? Were there alternative approaches that could have achieved the same goal with less surveillance?
Wastewater contains information about drug use, pharmaceutical use, and hormonal status in addition to viral pathogens. Should public health agencies be required to commit, in advance, to monitoring only specific substances and not others? Who should make that commitment, and how should it be enforced?
Wastewater surveillance is inherently aggregate at the community level but can be refined to the building level. Is there a principled ethical distinction between community-level and building-level wastewater monitoring? At what scale does wastewater monitoring become individual surveillance that requires individual consent?
The COVID-19 pandemic created conditions of genuine emergency that justified rapid deployment of wastewater surveillance without the usual processes of community consultation and consent. Now that the emergency has passed, what should happen to the infrastructure that was built? Should it be maintained, expanded, or scaled back? Who should make that decision?

This case study connects directly to Chapter 24 (epidemiological surveillance) and to Chapter 23's discussion of when environmental monitoring becomes human surveillance. Students should read this case study alongside Chapter 24's treatment of COVID-19 contact tracing and mobility data.